GSK drug Zejula helps ovarian cancer patients live longer in late-stage study Medical Dialogues Bureau16 July 2019 9:26 AM ISTGSK bought the drug when it acquired U.S. cancer specialist Tesaro for $5.1 billion in December and Zejula is already approved for certain ovarian...
US: Woman with cancer who used JnJ talcum powder awarded Rs 200 crore approx Garima15 March 2019 10:05 AM ISTJnJ said it would appeal, citing "serious procedural and evidentiary errors" in the course of the trial, saying lawyers for the woman had...
J&J passes asbestos test, allowed to make baby powder in India Farhat Nasim1 March 2019 2:28 PM ISTNEW DELHI: In a major relief to Johnson & Johnson(J&J), no asbestos was found in the baby powder manufactured in Baddi and Mulund plants. The...
Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer Farhat Nasim27 Feb 2019 9:30 AM ISTThe company has received US Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA), Gemcitabine for injection...
Another trouble for J&J: CDSCO seize samples of baby products for testing Farhat Nasim22 Dec 2018 12:14 PM ISTThe action by CDSCO has come at a time when the company is already embroiled in a controversy over its faulty hip implants. New Delhi: Following...
Asbestos scare: CDSCO draws samples of J&J baby powder from HP plant Medical Dialogues Bureau20 Dec 2018 5:12 PM ISTThe CDSCO, under the Union Health Ministry, said over the next four to five days, drug inspectors will search manufacturing plants and wholesalers of...
Biocon launches colon cancer drug in India, priced Rs 24,000 Ruby Khatun Khatun24 Nov 2017 10:01 AM ISTBengaluru: Biocon Ltd has launched KRABEVA, a biosimilar Bevacizumab for the treatment of patients with metastatic colorectal cancer and other types...
Intas Pharma cuts down price of cancer drug Bevacizumab by 60 percent Ruby Khatun Khatun6 Oct 2017 11:12 AM ISTAHMEDABAD: Intas Pharmaceuticals Limited, announced that the company is cutting down the cost of the cancer drug Bevacizumab by 60 percent in order to...
